Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Saxenda (active ingredient: liraglutide) subcutaneous injection Initial FDA Approval: 2014 (liraglutide approved in 2010) Side Effect Update Date: May 28, 2025 Medication Description: For chronic weight management Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
A personalized approach is often best
This is the hallmark of a homeostatic modulator rather than a direct agonist or antagonist
The DRD2 antagonist haloperidol mediates autophagy-induced ferroptosis to increase temozolomide sensitivity by promoting endoplasmic reticulum stress in glioblastoma
Branded Medications: Mounjaro and Zepbound are branded medications
Boysen NC, Stone MS (2014) Eosinophil-rich granulomatous panniculitis caused by exenatide injection
US$ 23.71
US$ 21.80
US$ 22.96
US$ 23.49
